ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC33936-10mM(1mLinWater) |
|
20724-73-6 |
NM107 (2’-C-Methylcytidine)
|
0 | C10H15N3O5 | |
GC33935-100mg |
|
51940-44-4 |
Pipemidic acid
|
0 | C14H17N5O3 | |
GC33935-10mM(1mLinDMSO) |
|
51940-44-4 |
Pipemidic acid
|
0 | C14H17N5O3 | |
GC33934-100mg |
|
13419-46-0 |
DCVC (S-[(1E)-1,2-dichloroethenyl]--L-cysteine)
|
0 | C5H7Cl2NO2S | |
GC33934-50mg |
|
13419-46-0 |
DCVC (S-[(1E)-1,2-dichloroethenyl]--L-cysteine)
|
0 | C5H7Cl2NO2S | |
GC33934-10mg |
|
13419-46-0 |
DCVC (S-[(1E)-1,2-dichloroethenyl]--L-cysteine)
|
0 | C5H7Cl2NO2S | |
GC33934-5mg |
|
13419-46-0 |
DCVC (S-[(1E)-1,2-dichloroethenyl]--L-cysteine)
|
0 | C5H7Cl2NO2S | |
GC33934-10mM(1mLinDMSO) |
|
13419-46-0 |
DCVC (S-[(1E)-1,2-dichloroethenyl]--L-cysteine)
|
0 | C5H7Cl2NO2S | |
GC33933-5g |
|
131-69-1 |
Phthalylsulfacetamide
|
0 | C16H14N2O6S | |
GC33933-10mM(1mLinDMSO) |
|
131-69-1 |
Phthalylsulfacetamide
|
0 | C16H14N2O6S | |
GC33932-50mg |
|
1428729-63-8 |
RIG-1 modulator 1
|
0 | C14H17N5OS2 | |
GC33932-10mg |
|
1428729-63-8 |
RIG-1 modulator 1
|
0 | C14H17N5OS2 | |
GC33932-5mg |
|
1428729-63-8 |
RIG-1 modulator 1
|
0 | C14H17N5OS2 | |
GC33932-1mg |
|
1428729-63-8 |
RIG-1 modulator 1
|
0 | C14H17N5OS2 | |
GC33932-10mM(1mLinDMSO) |
|
1428729-63-8 |
RIG-1 modulator 1
|
0 | C14H17N5OS2 | |
GC33931-1g |
|
8001-54-5 |
Benzalkonium chloride (Alkyldimethylbenzylammonium chloride)
|
0 | C6H5CH2N(CH3)2RCl (R=C8H17 to C18H37) | |
GC33930-100mg |
|
501-97-3 |
Desaminotyrosine (3-(4-Hydroxyphenyl)propionic acid)
|
0 | C9H10O3 | |
GC33930-10mM(1mLinDMSO) |
|
501-97-3 |
Desaminotyrosine (3-(4-Hydroxyphenyl)propionic acid)
|
0 | C9H10O3 | |
GC33929-5g |
|
138199-71-0 |
Levofloxacin hydrate (Levofloxacin hemihydrate)
|
0 | C18H20FN3O4 . 0.5H2O | |
GC33929-100mg |
|
138199-71-0 |
Levofloxacin hydrate (Levofloxacin hemihydrate)
|
0 | C18H20FN3O4 . 0.5H2O | |